Pigs and pacemakers Candace Stuart | July 17, 2014 | Cardiovascular Business | Heart RhythmResearchers at Cedars-Sinai Heart Institute in Los Angeles tested a “biological pacemaker” in pig hearts using gene therapy. The approach is at least three years away from human trials, the New York Times reports.Gene therapy is used to adjust pigs’ heartbeatSubscribe to Cardiovascular Business NewsEmail Address * Candace Stuart, Contributor Related ContentCardiologist performs first US implant of new heart deviceCardiology compensation climbs again—general cardiologists, electrophysiologists see biggest 2026 jumpsAI gaining ground in electrophysiology, but clinicians still run the showProfessional soccer player sues doctors, including her cardiologist, after in-game cardiac arrestBiotech company receives second grant to develop gene therapy for AFibJohnson & Johnson appears to exit LAA closure market, selling heart tech to new startupAround the webRadiology Business Maryland mammography law turns incidental cardiac findings into a new screening opportunityRadiology Business GE Healthcare to acquire radiopharma firm Sofie Biosciences for $945MRadiology Business Imaging artificial intelligence vendor Elucid raises $55MSubscribe to Cardiovascular Business NewsEmail Address * Subscribe to Cardiovascular Business NewsEmail Address *